1 active not recruiting, 1 not yet recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Not yet recruiting 1 |
Follow Anx007: new trials by email Literature Review of Anx007 trials Research Report on Anx007
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label Extension Study of the Long-Term Safety of Vonaprument (ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) Vonaprument - Geographic Atrophy | Phase 3 | Not yet recruiting | Annexon, Inc. | 605 | 2026-09-30 | 2026-09-08 |
| A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) Vonaprument, Sham Administration - Geographic Atrophy | Phase 3 | Active not recruiting | Annexon, Inc. | 659 | 2024-07-30 | 2026-10-06 |
Annexon, Inc. (2)
United States (2) · Australia (1) · Austria (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1) · New Zealand (1) · Poland (1) · Spain (1) · United Kingdom (1)